Altimmune (ALT) Leases (2019 - 2024)
Historic Leases for Altimmune (ALT) over the last 6 years, with Q4 2024 value amounting to $1.6 million.
- Altimmune's Leases rose 35151.52% to $1.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.6 million, marking a year-over-year increase of 35151.52%. This contributed to the annual value of $1.6 million for FY2024, which is 35151.52% up from last year.
- As of Q4 2024, Altimmune's Leases stood at $1.6 million, which was up 35151.52% from $1.7 million recorded in Q3 2024.
- Altimmune's 5-year Leases high stood at $1.7 million for Q2 2024, and its period low was $300000.0 during Q1 2024.
- Moreover, its 5-year median value for Leases was $725500.0 (2022), whereas its average is $815270.6.
- The largest annual percentage gain for Altimmune's Leases in the last 5 years was 35151.52% (2024), contrasted with its biggest fall of 4454.71% (2024).
- Quarter analysis of 5 years shows Altimmune's Leases stood at $903825.0 in 2020, then dropped by 11.71% to $798000.0 in 2021, then fell by 25.31% to $596000.0 in 2022, then crashed by 39.09% to $363000.0 in 2023, then soared by 351.52% to $1.6 million in 2024.
- Its Leases was $1.6 million in Q4 2024, compared to $1.7 million in Q3 2024 and $1.7 million in Q2 2024.